Clobederm NN Ointment 15gm Indications
Clobederm NN Oint 15gm is primarily indicated in conditions like Decontamination of digestive tract, Hepatic coma, Hepatic encephalopathy, Pre-operative bowel sterilization, Sepsis, Skin infections, Superficial infections, and can also be given in adjunctive therapy as an alternative drug of choice in Acute bacterial enteritis, Bladder infections, Hypercholesterolaemia, Wounds management.
Clobederm NN Oint 15gm is contraindicated in conditions like Allergy,Myasthenia gravis, Parkinsonism,Intestinal obstruction, Perforation of eardrum,Renal impairment.
The severe or irreversible adverse effects of Clobederm NN Oint 15gm, which give rise to further complications include Urticaria, Angioneurotic edema, Ototoxicity, Blood dyscrasias, blood dyscrasias. Clobederm NN Oint 15gm produces potentially life-threatening effects which include Anaphylactic shock, Renal failure, Skeletal muscle paralysis, Superinfection. which are responsible for the discontinuation of Clobederm NN Oint 15gm therapy. The signs and symptoms that are produced after the acute overdosage of Clobederm NN Oint 15gm include Permanent deafness. The symptomatic adverse reactions produced by Clobederm NN Oint 15gm are more or less tolerable and if they become severe, they can be treated symptomatically, these include Vertigo, Headache, Diarrhea, Tinnitus, Pruritus, Lethargy, Skin rash, Contact dermatitis, Pyuria, Steatorrhea, Azotemia, Cylindruria, Contact dermatitis.
Clobederm NN Oint 15gm should be used with caution in patients who are sensitive to aminoglycosides, renal disease or renal impairment, patients with dehydration and in elderly patients. Patient with pre-existing tinnitus, vertigo or subclinical high frequency hearing impairrment should be closely monitored for sign of ototoxicity during therapy with Clobederm NN Oint 15gm. Take appropriate measures in case of secondary infections. Parenteral use of Clobederm NN Oint 15gm or its use for irrigation of wound or serouse cartities is no longer recommended.